08.05.2020 With immediate effect: 3 million proven antibody tests for SARS-CoV-2 and mastermix ready-to use PCR tests. 17 million more antibody tests available.
Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release
Highly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS and AML Click here to view full Press release
/wp-content/uploads/2017/03/logoBlueNew3.png00Admin medac/wp-content/uploads/2017/03/logoBlueNew3.pngAdmin medac2018-03-26 08:56:282020-07-02 17:07:01Press release – Results of phase III study with Treosulfan, EMA approval pending
Enhancing the potential of methotrexate. Optimise rheumatism treatment in Finland with Metoject® PEN and ensure long-term success of therapy Helsinki / Wedel (September 21, 2017). There is room for improvement in drug treatment of rheumatoid arthritis (RA) with the gold standard methotrexate (MTX). Current analyses of the FIN-ERA cohort suggest that Finnish rheumatology exploits the […]
Press Release – medac Diagnostics: a complete package for COVID-19 testing
/in kategorioimaton /by Super Ezy08.05.2020 With immediate effect: 3 million proven antibody tests for SARS-CoV-2 and mastermix ready-to use PCR tests. 17 million more antibody tests available.
Press Release – medac Diagnostics Portfolio
/in kategorioimaton /by Super Ezy08.05.2020 With immediate effect: medac´s proven methods for SARS-CoV-2 testing for the German-speaking world
Press release – First marketing authorisation worldwide for methotrexate in moderate psoriasis
/in kategorioimaton /by Admin medacMedac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release
Press release – Results of phase III study with Treosulfan, EMA approval pending
/in kategorioimaton /by Admin medacHighly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS and AML Click here to view full Press release
Press release – Medac Finland – 10-years anniversary symposium
/in kategorioimaton /by Admin medacEnhancing the potential of methotrexate. Optimise rheumatism treatment in Finland with Metoject® PEN and ensure long-term success of therapy Helsinki / Wedel (September 21, 2017). There is room for improvement in drug treatment of rheumatoid arthritis (RA) with the gold standard methotrexate (MTX). Current analyses of the FIN-ERA cohort suggest that Finnish rheumatology exploits the […]